Circulating angiogenic factors in pregnancies complicated by pre-eclampsia

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Reproductive Biology

Background:

• Pre-eclampsia is an inflammatory disorder linked to endothelial dysfunction.
• Impaired trophoblast invasion during implantation may contribute to pre-eclampsia.
• Maternal serum levels of VEGF, PIGF, and sFlt-1 are altered in pre-eclampsia.

Purpose of the Study:

• To investigate serum concentrations of VEGF, PIGF, and sFlt-1 in Indian patients with pre-eclampsia.
• To determine if pre-eclampsia is associated with specific changes in these angiogenic factors.

Main Methods:

• A case-control study was conducted.
• Serum samples from 40 women with pre-eclampsia and 40 normotensive controls were analyzed.
• Enzyme-linked immunosorbent assay (ELISA) was used to measure VEGF, PIGF, and sFlt-1 levels.

Main Results:

• Significantly higher sFlt-1 levels were observed in women with pre-eclampsia compared to controls.
• Significantly lower levels of free VEGF and PIGF were found in women with pre-eclampsia.
• Statistical significance (p < 0.0001) was noted for all observed differences.

Conclusions:

• Elevated sFlt-1 and reduced free VEGF and PIGF suggest an angiogenic imbalance in pre-eclampsia.
• This imbalance in pro- and anti-angiogenic factors may play a role in pre-eclampsia pathogenesis.
• Findings highlight potential biomarkers for pre-eclampsia.